Atypical antipsychotics in the treatment of bipolar disorder

被引:8
作者
Strakowski, SM
Del Bello, MP
Adler, CM
Keck, PE
机构
[1] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Dept Psychiat,Vet Affairs Med Ctr, Mental Hlth Serv Line & Gen Clin Res Ctr, Cincinnati, OH USA
关键词
aripiprazole; atypical antipsychotics; bipolar disorder; olanzapine; quetiapine; risperidone; ziprasidone;
D O I
10.1517/14656566.4.5.751
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Atypical antipsychotic medications are widely used for the treatment of bipolar disorder. Most empirical support suggests that these medications are efficacious in the treatment of acute mania, but there is considerably less support for the utility of these drugs in other phases of bipolar disorder. However, it is likely that several of these drugs will demonstrate efficacy in relapse prevention, and perhaps antidepressant efficacy in bipolar disorder as more studies are conducted. Atypical antipsychotics offer different side effect profiles than older antipsychotics, which may be of benefit for some patients. Consequently, atypical antipsychotics provide an important treatment option for bipolar patients.
引用
收藏
页码:751 / 760
页数:10
相关论文
共 56 条
[11]   Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects [J].
Halbreich, U ;
Kinon, BJ ;
Gilmore, JA ;
Kahn, LS .
PSYCHONEUROENDOCRINOLOGY, 2003, 28 :53-67
[12]  
HIRSCHFELD R, 2002, 41 ANN M AM COLL NEU
[13]   COMPARATIVE EFFECTS OF LITHIUM AND CHLORPROMAZINE IN TREATMENT OF ACUTE MANIC STATES [J].
JOHNSON, G ;
GERSHON, S ;
BURDOCK, EI ;
FLOYD, A ;
HEKIMIAN, L .
BRITISH JOURNAL OF PSYCHIATRY, 1971, 119 (550) :267-&
[14]   In vivo 5-HT2A receptor blockade by quetiapine -: An R91150 single photon emission tomography study [J].
Jones, HM ;
Travis, MJ ;
Mulligan, R ;
Bressan, RA ;
Visvikis, D ;
Gacinovic, S ;
Ell, PJ ;
Pilowsky, LS .
PSYCHOPHARMACOLOGY, 2001, 157 (01) :60-66
[15]   A positron emission tomography study of quetiapine in schizophrenia -: A preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy [J].
Kapur, S ;
Zipursky, R ;
Jones, C ;
Shammi, CS ;
Remington, G ;
Seeman, P .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (06) :553-559
[16]   Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo controlled trial [J].
Keck, P ;
Buffenstein, A ;
Ferguson, J ;
Feighner, J ;
Jaffe, W ;
Harrigan, EP ;
Morrissey, MR .
PSYCHOPHARMACOLOGY, 1998, 140 (02) :173-184
[17]  
Keck P E Jr, 2001, Expert Opin Pharmacother, V2, P1033
[18]   Ziprasidone in the short-term treatment of patients with schizoaffective disorder: Results from two double-blind, placebo-controlled, multicenter studies [J].
Keck, PE ;
Reeves, KR ;
Harrigan, EP .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (01) :27-35
[19]  
Keck PE, 1998, J CLIN PSYCHIAT, V59, P74
[20]  
KECK PE, 2003, IN PRESS AM J PSYCHI